Lorati, a Taiwan-based biotechnology and skincare company, today announced that it has successfully developed nano-medication, which can effectively inhibit HIV-1 viral replication.
Lorati CEO, David Lo, said nano-medication, based on bentonite, also known as God’s dirt, is believed to be the last-ditch treatment for AIDS. According to the company, ‘unbelievable improvement’ can be obtained within one month of treatment by nano-medication. After being treated for a couple of months, AIDS patients can even go back to HIV-1 status, meaning the number…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
